Wide range of Copilot+ PCs,including both laptops and desktops,equipped with the latest processors with integrated NPUs that deliver the performance needed to run demanding AI workloads
Jan 8, 2025
Aston Martin Aramco announce long-term partnership with Pepperstone A global leader in online trading,Pepperstone joins as Global Forex and Trading Partner
Jan 8, 2025
NEW YORK,Jan. 7,2025-- Aquaron Acquisition Corp. (NASDAQ: AQU,the "Company"),a special purpose acquisition company,announced today that HUTURE Ltd. ("Huture") has deposited into th
Jan 8, 2025
MILPITAS,Calif.,Jan. 7,2025-- Amazfit,a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP),a health technology company,today announced the launch of its latest lifestyle smartwatc
Jan 8, 2025
SUZHOU,China,Jan. 7,2025--Suzhou China Star Optoelectronics Technology Co.,Ltd. ("TCL CSOT Suzhou") has joined the Science Based Targets initiative (SBTi),reinforcing its commitment to scien
Jan 8, 2025
LAS VEGAS,Jan. 6,2025-- With unmatched 21 jolt angles and 3 degrees of freedom in motion capture,UDCAP VR Glove has raised nearly $600,000 in crowdfunding on Kickstarter. Thousands of users worldwide
Jan 8, 2025
Whale TV Profit Sharing Program Announced for TV Brands Whale TV+ Now Available on All Whale TV Models
Jan 8, 2025
"Tires,Batteries,Thermal Management": Completing Three Core Portfolios to Become a Global High-Tech Leading Group
Jan 8, 2025
HONG KONG,Jan. 7,2025-- Eyebright Medical Technology (Beijing) Co.,Ltd. ("Eyebright Medical",the "Company",Stock Code: 688050.SH,together with its subsidiaries collectively known
Jan 8, 2025
XI\'AN,China,Jan. 6,2025-- zMaticoo,an emerging leader of advanced programmatic advertising solutions,is proud to officially announce its recent achievement of Google SDK Index Certification.
Jan 8, 2025
LAS VEGAS,Jan. 8,2025-- UGREEN,a leading innovator in consumer electronics,is due to showcase its latest innovations at CES 2025 under the theme of "Activate the Possibility of AI." The high
Jan 8, 2025
Avenzo to receive exclusive global license (excluding Greater China) for development,manufacturing and commercialization of potential best-in-class EGFR/HER3 antibody-drug conjugate
Jan 8, 2025
© Voice Of Zimbabwe Privacy Policy Contact us